Cite
HARVARD Citation
Holmer, A. et al. (2020). Biomarkers are associated with clinical and endoscopic outcomes with vedolizumab treatment in Crohn's disease. Therapeutic advances in gastroenterology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Holmer, A. et al. (2020). Biomarkers are associated with clinical and endoscopic outcomes with vedolizumab treatment in Crohn's disease. Therapeutic advances in gastroenterology. p. . [Online].